Journal article · Vestibular← The news desk

✦ The Dispatch

Vestibular schwannoma with hemorrhage in a 63-year-old female: A case report

A dispatch from PubMed — filed

Vestibular schwannomas are benign cranial nerve tumors that typically follow an indolent course. Management strategies are guided by tumor size, growth rate, and neurological compression. However, a small proportion show aggressive behavior characterized by rapid expansion, cystic degeneration, or spontaneous intratumoral hemorrhage, resulting in acute neurological deterioration....

Clinical Takeaway

Intratumoral hemorrhage is a rare but serious complication of vestibular schwannoma; management decisions should integrate tumor size, growth rate, and neurological status — no change to standard practice is indicated by this single case.

Why It Matters

Hemorrhagic vestibular schwannoma is uncommon and can mimic stroke or other emergencies; awareness of this presentation is important for timely and appropriate referral.

Key Points
  1. 01Vestibular schwannoma with intratumoral hemorrhage is a rare but documented complication.
  2. 02A 63-year-old female patient is described with management guided by tumor size, growth rate, and neurological factors.
  3. 03The case illustrates the importance of individualized treatment planning for vestibular schwannoma.
  4. 04Hemorrhagic schwannoma can present acutely and may mimic other neurological emergencies.
  5. 05Management options for vestibular schwannoma include observation, radiosurgery, and microsurgery.
Claims & Evidence

Management of vestibular schwannoma with hemorrhage should be guided by tumor size, growth rate, and neurological factors.

studypartially supported
Research metadata
PMID
42403646
DOI
10.1016/j.radcr.2026.05.078.
Journal
Radiology Case Reports
Publication type
case_report
Evidence level
4
Sample size
1
Population
63-year-old female with vestibular schwannoma and intratumoral hemorrhage
Intervention
Management of hemorrhagic vestibular schwannoma

Primary outcomes

Management strategy selection based on tumor size, growth rate, and neurological status

Related stories